NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

Someone called my attention to this article on a GBM trial, it may be an improvement on the SOC, but I don't believe it holds a candle to what we're doing. That's not to say that in combination with DCVax-L it might not be more effective.

https://app.quotemedia.com/quotetools/newsStoryPopup.go?storyId=6266387527501332&topic=KZIA&symbology=null&cp=null&webmasterId=91027

Look at their survival figures, in our case, I believe the greatest benefit is for the roughly 25% who'll live 5 years and beyond, many having a normal life. I don't know exactly how well our other figures will stack up.

Gary